Investigative Sites

India continues to gain the attention of pharmaceutical companies looking for a place to conduct clinical trials because of the country's reputation for fast subject recruitment rates. But as Jane Barrett reveals, sometimes the country's clinical trial participants are more uninformed than informed.

The importance of human subject protection, clear communication, and community spirit are among the issues emerging from the tragedy.

Yesterday's SMOs have given way to a new service provider that should be recognized.

This case study shows how Internet-based clinical trials improve data entry, monitoring, and management.

Teaming up with a staffing partner can help companies find the right CRA for their trial.

Electronic solutions can enhance the efficiency of tracking drugs throughout a clinical trial.

Common barriers to enrollment can be overcome by using targeted recruitment strategies.

Electronic health records are a viable alternative to today's subject recruitment methods.

Study findings show class attendance improves the outcome of CRA audits.

A common set of rules for ensuring a two-way flow of information and addressing subjects' needs.

With the help of Microsoft, Broadpeak and DataLabs prove seamless integration is possible.

Increasing cultural awareness is key to helping the country meet recruitment challenges.

Europe is moving toward more intense patient contact through a variety of media.

Lack of adequate and attentive support is preventing some sites from fully taking advantage of EDC and ePRO technologies.

Despite requirements for consent forms at lower grade levels, evaluation studies find little or no improvement in understanding.

Strategies for eliminating factors that influence the placebo response during the clinical trial process.

To run productive, results-oriented meetings, you must understand how people hear and how they remember.

Survey results point to a correlation between clinical trial awareness and a willingness to enroll.

Performance, compliance, and financial pressures are hitting investigators hard. What can sponsors and CROs do to help the situation?

Following the model of the home health care industry might be the answer to high subject dropout rates in clinical trials.

True translation specialists do more than just interpret your words. They interpret your intentions as well.

The aim of the study was to collect information from all individuals who assisted with COG CRA functions.

With the advent of personalized medicine and purported "race-based therapies" such as BilDil in the news, it is time the pharmaceutical industry makes a more concerted effort to engage racial and ethnic minority groups and the rural poor in clinical research.